chr2-218992208-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2

The NM_057093.2(CRYBA2):ā€‹c.197A>Gā€‹(p.Gln66Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000027 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CRYBA2
NM_057093.2 missense

Scores

1
12
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.04
Variant links:
Genes affected
CRYBA2 (HGNC:2395): (crystallin beta A2) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of the vertebrate eye, which function to maintain the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also defined as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group but absent in the acidic group). Beta-crystallins form aggregates of different sizes and are able to form homodimers through self-association or heterodimers with other beta-crystallins. This gene is a beta acidic group member. Three alternatively spliced transcript variants encoding identical proteins have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM1
In a chain Beta-crystallin A2 (size 196) in uniprot entity CRBA2_HUMAN there are 4 pathogenic changes around while only 1 benign (80%) in NM_057093.2
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CRYBA2NM_057093.2 linkuse as main transcriptc.197A>G p.Gln66Arg missense_variant 2/4 ENST00000295728.7 NP_476434.1 P53672A0A024R429
CRYBA2NM_057094.2 linkuse as main transcriptc.197A>G p.Gln66Arg missense_variant 3/5 NP_476435.1 P53672A0A024R429

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CRYBA2ENST00000295728.7 linkuse as main transcriptc.197A>G p.Gln66Arg missense_variant 2/41 NM_057093.2 ENSP00000295728.2 P53672
CRYBA2ENST00000392096.6 linkuse as main transcriptc.197A>G p.Gln66Arg missense_variant 3/51 ENSP00000375946.2 P53672
CRYBA2ENST00000453769.1 linkuse as main transcriptc.197A>G p.Gln66Arg missense_variant 3/43 ENSP00000395120.1 C9JDH2
CRYBA2ENST00000490678.1 linkuse as main transcriptn.199A>G non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000274
AC:
4
AN:
1461372
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
726990
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 18, 2023The c.197A>G (p.Q66R) alteration is located in exon 2 (coding exon 2) of the CRYBA2 gene. This alteration results from a A to G substitution at nucleotide position 197, causing the glutamine (Q) at amino acid position 66 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.56
D;D;T
Eigen
Benign
0.11
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.89
.;D;T
M_CAP
Benign
0.014
T
MetaRNN
Uncertain
0.61
D;D;D
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
-0.20
N;N;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-2.8
D;D;D
REVEL
Uncertain
0.54
Sift
Uncertain
0.015
D;D;D
Sift4G
Benign
0.14
T;T;.
Polyphen
0.55
P;P;.
Vest4
0.46
MutPred
0.55
Gain of sheet (P = 0.1539);Gain of sheet (P = 0.1539);Gain of sheet (P = 0.1539);
MVP
0.86
MPC
0.45
ClinPred
0.98
D
GERP RS
4.5
Varity_R
0.61
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-219856930; API